Cancer / Immunology
Merck's JAVELIN Bladder Regimen Shines in Real-World Data, Elevating Standard Care for Urothelial Carcinoma
Merck, a distinguished science and technology company, has announced groundbreaking real-world data that further solidify the JAVELIN Bladder regimen as a ...
January 23, 2024 | News
AstraZeneca's IMFINZI Combo Shows Significantly Improved Survival in Liver Cancer
Positive results from the EMERALD-1 Phase III trial showed AstraZeneca’s IMFINZI® (durvalumab) in combination with TACE and bevacizumab demo...
January 22, 2024 | News
BostonGene and Prisma Health Collaborate to Predict Immunotherapy Efficacy in Rare Cancers
BostonGene, a leading provider of AI-based molecular and immune profiling solutions provider, today announces a collaboration with Prisma Health aimed at a...
January 19, 2024 | News
Qure.ai and Project Data Sphere Merge Big Pharma Insights with Deep AI for Advancing Cancer Care
In a pivotal stride toward advancing cancer care, Qure.ai, a leader in artificial intelligence (AI) solutions for medical imaging, and Project Data Sp...
January 19, 2024 | News
CMS Grants Favorable Reimbursement for RefleXion’s SCINTIX Therapy
The CMS has established a national payment rate for RefleXion's SCINTIX® biology-guided radiotherapy using CMS' New Technology Ambulatory Payment Class...
January 16, 2024 | News
CARsgen's CT011 Granted NMPA IND Clearance for GPC3-Positive Stage Ⅲa Liver Cancer
CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on innovative CAR T-cell therapies for the treatment of hematologic malignan...
January 16, 2024 | News
Merck Expands Colorectal Cancer Portfolio Through Licensing Agreement with Inspirna
First-in-class ompenaclid (RGX-202) currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer Collaboration includes ex...
January 09, 2024 | News
Guardant Health, Hikma Partner for Cancer Testing in the Middle East and North Africa
The partnership expands Guardant Health's global presence and includes products across the cancer care continuum. The tests offered include Shield™ f...
January 09, 2024 | News
Menarini Group and Insilico Medicine Ink Exclusive Deal for Novel KAT6 Inhibitor in Oncology, Including Breast Cancer Treatment
KAT6 is an emerging target in hormone sensitive breast tumors and other cancers. Overexpression of KAT6A/B correlates with poor clinical outcomes in...
January 05, 2024 | News
Merck Broadens Colorectal Cancer Portfolio via Licensing Deal with Inspirna
First-in-class ompenaclid (RGX-202) currently in Phase II development for RAS-mutated advanced or metastatic colorectal cancer Collaboration includes ex...
January 05, 2024 | News
Clover's SCB-219M Shows Positive Phase I Results for Chemotherapy-Induced Thrombocytopenia (CIT) Treatment
--All CIT patients maintained platelet counts >75 x 109/L at 1-week following chemotherapy plus a single dose of SCB-219M, with durable responses t...
December 29, 2023 | News
RemeGen's RC88 Granted FDA IND Approval for Platinum-Resistant Ovarian Cancer
The open-label, randomized, dose optimization phase 2 study aims to enroll participants in multiple countries to further clarify the optimal dosage...
December 29, 2023 | News
BioCity Doses First Patient in Phase Ib/II Trial of BC3402 Anti-TIM-3 mAb with IMFINZI for Advanced Hepatocellular Carcinoma
The study is being conducted at Zhongshan Hospital with Prof. Jia Fan as the principal investigator. Dr. Fan is a world-renowned liver cancer sur...
December 21, 2023 | News
Advancing Lung Cancer Treatment: Insights from Professor Benjamin Solomon on the ALINA Study and the Future of ALK-Positive NSCLC
In an exclusive BioPharma APAC interview, Professor Benjamin Solomon, a distinguished Medical Oncologist at the Peter MacCallum Cancer Centre, Australia, a...
December 18, 2023 | News
Most Read
- Biotech and Biopharma Industry Trends: What to Watch for in 2024
- Revolutionizing Drug Discovery: 15 AI Companies to Watch in 2024
- Pioneering Precision: Top 15 Clinical and Lab Diagnostic Companies to Watch in 2024
- 2024's Biopharma Roadmap: Top 24 Biopharma Trends to Watch in 2024
- Breakthroughs Unveiled: A Year of Groundbreaking Novel Drug Approvals in 2023
- Revolutionizing Tomorrow: Top 24 Emerging Biotech Innovations to Watch in 2024
Bio Jobs
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
- Cordlife Accelerates Lab and Technical Staff Recruitment to Rebuild Foundation and Strengthen Core Processes in Singapore
- Padraig McDonnell Takes Helm as Agilent Technologies' New CEO, Pledges to Elevate Scientific Impact
- Agilent Singapore and Malaysia Hosts CEO Transition Event: Celebrating Leadership and Welcoming New CEO
- Leica Microsystems Announces Vacancy for Senior Imaging FPGA Testing Engineer in Singapore
- Glen Godresse Takes Helm as CEO of Menarini Asia-Pacific
News
Editor Picks
